𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

✍ Scribed by Frits-Axel Wiesel; A. -L. Nordström; L. Farde; Bo Eriksson

Publisher
Springer
Year
1994
Tongue
English
Weight
740 KB
Volume
114
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open study of risperidone liquid in t
An open study of risperidone liquid in the acute phase of schizophrenia
✍ Reiji Yoshimura; Jun Nakamura; Koji Shinkai; Makiko Goto; Yasuhisa Yamada; Kyoko 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract An open‐label study was performed to investigate the clinical efficacy and mechanisms of risperidone liquid in ameliorating positive symptoms in the acute phase of schizophrenia. Eighty‐eight patients (M/F: 50/38; age: 18–74 years;, mean±SD =32±16 years) meeting DSM‐IV criteria for schi

Augmentation of atypical antipsychotics
Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia
✍ Takefumi Suzuki; Hiroyuki Uchida; Hiroyoshi Takeuchi; Shinichiro Nakajima; Kensu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract ## Objective Most difficult inpatients with schizophrenia are in serious needs but obviously underrepresented in clinical trials. ## Methods Very challenging patients received open‐label treatment with atypical antipsychotics concurrently augmented with valproic acid. The primary out

The acute and long-term effectiveness of
The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study
✍ Yong Min Ahn; Kyu Young Lee; Chul-Eung Kim; Dae-Yeob Kang; Jeong-Ho Seok; Young 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Objective To compare the effectiveness of amisulpride in acute (up to 8 weeks) and maintenance (week 8 to 12 months) phases of a 12‐month course of treatment in a heterogeneous group of patients with schizophrenia. ## Methods We conducted a 12‐month, open‐label clinical trial with flexible dos